Neil Solomons M.D. — Chief Medical Officer at Aurinia Pharmaceuticals | Comparably
Isotechnika Pharma Inc. is a biopharmaceutical company focused on the discovery and development of immunomodulating therapeutics designed read more
EMPLOYEE
PARTICIPANTS
6
TOTAL
RATINGS
49
Neil Solomons M.D. — Chief Medical Officer at Aurinia Pharmaceuticals

Neil Solomons M.D. — Chief Medical Officer at Aurinia Pharmaceuticals

Executive Bio

Dr. Neil Solomons, M.D. has been the Chief Medical Officer at Aurinia Pharmaceuticals Inc. since September 23, 2013. Dr. Solomons is responsible for managing, developing, guiding and coordinating Aurinia's clinical development group and its activities. He is also Aurinia's senior medical spokesperson to investigators, scientific advisors and investors. He is an experienced pharmaceutical physician with 15 years of clinical development and medical affairs experience in both big pharma and biotech. He is a recognised expert in rare-disease drug development and is widely published in this field. He joins Aurinia from Vifor Pharma, formerly Aspreva pharmaceuticals (NASDAQ:ASPV) where he served as Vice President, Research and Development being the lead clinician in the development of CellCept??? in rare diseases. He led the CellCept Clinical Development teams of over 50 people that saw the completion, reporting and publication of studies in pemphigus vulgaris, myasthenia gravis, both industry firsts and the successful landmark lupus nephritis study called the Aspreva Lupus Management Study (ALMS). He was responsible for all clinical development activities from Phases 1 to 3, as well as participating in the formulation of R&D strategy, portfolio management and due diligence efforts. He served as Chief Medical Officer of Isotechnika Pharma Inc. He served a variety of positions at Roche in both Global Clinical Development and Medical Affairs in transplantation, virology and auto-immune diseases. While at Roche, Dr. Solomons led a diverse team in the development and implementation of post-marketing studies with a budget exceeding $15 million for its transplantation (CellCept??? and Zenapax???) and virology (Cytovene???) franchises. He qualified in medicine in 1991 received his MB BS (MD) at Guys Hospital Medical School, London.
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Chief Medical Officer
$245k
$402k

Executive Team Culture Ratings from Aurinia Pharmaceuticals Employees

BOTTOM
5%
Aurinia Pharmaceuticals' Executive Team scores in the Bottom 5%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Aurinia Pharmaceuticals
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Aurinia Pharmaceuticals

Aurinia Pharmaceuticals' Executive Team at a Glance

Based on 2 ratings, Aurinia Pharmaceuticals' employees are less satisfied with their Executive Team and give them a ā€œFā€ or 45/100.

Aurinia Pharmaceuticals' Executive Team ranks in the Bottom 5% of other companies in Victoria, TX and Bottom 5% of other companies on Comparably that also have 11-50 Employees.

×
Rate your company